Baqsimi 3 MG Nasal Powder

RxCUI: 2180671
RxNorm name: Baqsimi 3 MG Nasal Powder
Display name: Baqsimi 3 MG Nasal Powder
Full name: Baqsimi 3 MG Nasal Powder
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Baqsimi	GLUCAGON	Sportpharm LLC	32ba41fa-4158-40af-8cb2-03693c248994	2026-06-19	Warnings, Adverse reactions	Exact identifier rxcui: 2180671
Baqsimi	GLUCAGON	Amphastar Pharmaceuticals, Inc.	f1f5df9b-872f-44e5-a18f-f0b68e7e9254	2025-08-06	Warnings, Adverse reactions	Exact identifier rxcui: 2180671

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f1f5df9b-872f-44e5-a18f-f0b68e7e9254	baqsimi 3 MG Nasal Powder [PSN] · glucagon 3 MG Nasal Powder [Baqsimi] [SBD] · Baqsimi 3 MG Nasal Powder [SY]	3	6	These highlights do not include all the information needed to use BAQSIMI safely and effectively. See full prescribing information for BAQSIMI. BAQSIMI (glucagon) nasal powder Initial U.S. Approval: 1960	20250806